Consensus panel recommendations for the assessment and management of breakthrough pain: Part 2 management

Daniel Bennett, Allen W. Burton, Scott M Fishman, Barry Fortner, Bill McCarberg, Chris Miaskowski, David Nash, Marco Pappagallo, Richard Payne, James Ray, Eugene Viscusi, Winston Wong

Research output: Contribution to journalArticle

104 Scopus citations

Abstract

The authors continue their discussion of pharmacological and nonpharmacological therapies with a focus on criteria for the best agent, the subtypes of breakthrough pain, and the economic and quality-of life considerations.

Original languageEnglish (US)
Pages (from-to)354-361
Number of pages8
JournalP and T
Volume30
Issue number6
StatePublished - Jun 2005

ASJC Scopus subject areas

  • Pharmacology

Fingerprint Dive into the research topics of 'Consensus panel recommendations for the assessment and management of breakthrough pain: Part 2 management'. Together they form a unique fingerprint.

  • Cite this

    Bennett, D., Burton, A. W., Fishman, S. M., Fortner, B., McCarberg, B., Miaskowski, C., Nash, D., Pappagallo, M., Payne, R., Ray, J., Viscusi, E., & Wong, W. (2005). Consensus panel recommendations for the assessment and management of breakthrough pain: Part 2 management. P and T, 30(6), 354-361.